Verified Nov 2026
Other
·

Paris, Ile-de-France
·
Since 2017
Curium Pharma develops, manufactures, and distributes radiopharmaceutical products for diagnostic imaging and cancer treatment. Founded in 2017 and headquartered in Paris with operational hubs in Boston and St. Louis, the company employs 5,000–10,000 people and generates estimated revenue of $500 million to $1 billion. It serves healthcare facilities across more than 60 countries in oncology, diagnostic imaging, and related medical fields.
Curium Pharma at a glance
Revenue
$500M-1B
Est. band
Employees
5,000-10,000
Founded
2017
Headquarters
Paris, Ile-de-France
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Overview
Curium Pharma develops, manufactures, and distributes radiopharmaceutical products for diagnostic imaging and cancer treatment. Founded in 2017 and headquartered in Paris with operational hubs in Boston and St. Louis, the company employs 5,000–10,000 people and generates estimated revenue of $500 million to $1 billion. It serves healthcare facilities across more than 60 countries in oncology, diagnostic imaging, and related medical fields.
At a glance
Attribute | Detail |
|---|---|
Founded | 2017 |
Headquarters | Paris, Ile-de-France |
Employees | 5,000-10,000 |
Revenue | $500M-1B (estimated) |
What Curium Pharma makes
Curium offers SPECT and PET imaging agents for disease visualization, therapeutic radiopharmaceuticals for conditions including prostate cancer and neuroendocrine tumors, and cGMP contract manufacturing services.
Latest developments
2026-09-28 — Curium expands long-standing collaboration with the University of Missouri Research Reactor to strengthen the U.S. supply chain for a critical cancer isotope - Curium Pharma (curiumpharma.com)
2026-08-10 — Curium acquires Abscint SA, expanding PET radiodiagnostic pipeline in oncology - Curium Pharma (curiumpharma.com)
2026-08-03 — Curium Announces Definitive Agreement to Merge with Lantheus - Curium Pharma (curiumpharma.com)
2026-07-30 — Curium advances plans for second investment in Romania to expand access to advanced nuclear medicine - Curium Pharma (curiumpharma.com)
2026-06-01 — Curium Announces a Strategic Investment of Over €32 million in Saclay, France - Curium Pharma (curiumpharma.com)
2025-12-03 — Curium Establishes Legal Entity in China - Curium Pharma (curiumpharma.com)
Facilities
Curium Pharma is headquartered in Paris, Ile-de-France. Public sources also reference these locations:
St Louis, MO — curiumpharma.com
Paris, France — curiumpharma.com
St Louis, Missouri — curiumpharma.com
Boston, Massachusetts — curiumpharma.com
Company details
The company serves more than 14 million patients annually across its global network and completed a definitive merger agreement with Lantheus in August 2026. Curium Pharma was founded in 2017, has an estimated 5,000-10,000 employees, and is headquartered in Paris, Ile-de-France.
Frequently asked questions
What does Curium Pharma do?
Curium Pharma develops, manufactures, and distributes radiopharmaceutical products for diagnostic imaging and cancer treatment. Founded in 2017 and headquartered in Paris with operational hubs in Boston and St. Louis, the company employs 5,000–10,000 people and generates estimated revenue of $500 million to $1 billion. It serves healthcare facilities across more than 60 countries in oncology, diagnostic imaging, and related medical fields.
Where is Curium Pharma headquartered?
Curium Pharma is headquartered in Paris, Ile-de-France (20 Rue Quentin-Bauchart, Paris, Ile-de-France, 75008).
When was Curium Pharma founded?
Curium Pharma was founded in 2017.
How big is Curium Pharma?
Curium Pharma has an estimated 5,000-10,000 employees, with revenue in the $500M-1B range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
